EUVIMEDEUVIMED entdecken
Crossref

Development and validation of an LC–MS/MS method for the determination of AZD7648 in rat plasma: Application to a pharmacokinetic study

Xun Fang, Qi Lu, Jichun Han iD

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Xun Fang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Yingshang People's Hospital, Fuyang, Anhui Province, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AZD7648 is a potent DNA‐PK inhibitor that is being developed for the treatment of ovarian cancer. The study aimed to develop a simple and sensitive liquid chromatography–tandem mass spectrometry (LC–MS/MS) method to determine the concentration of AZD7648 in rat. AZD7648 was extracted from plasma by acetonitrile‐mediated protein precipitation. The quantification was performed on a Thermo Vantage TSQ mass spectrometer with ibrutinib as an internal standard. A Waters Acquity UPLC BEH C 18 column combined with 0.1% aqueous formic acid and acetonitrile was employed for chromatographic separation. The precursor‐to‐product ion transitions were m/z 421.2 > 337.2 and m/z 441.2 > 138.1 for AZD7648 and internal standard, respectively. This method was successfully validated according to the US Food and Drug Administration guidance. The calibration curve was linear over the concentration range of 0.5–1,000 ng/ml with correlation coefficient >0.999. The precision expressed as the coefficient of variation was 94.49%. AZD7648 was stable in rat plasma after storage under certain conditions. The validated method was demonstrated to be selective, sensitive and reliable, and has been successfully applied to the pharmacokinetic study of AZD7648 in rat plasma after oral and intravenous administration (1 mg/kg).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryRatsAnimalsChromatography, LiquidAcetonitrilesReproducibility of ResultsChromatography, High Pressure LiquidPurinesPyransTriazoles

Stichwörter der Autor:innen

AZD7648LC-MS/MSbioavailabilitypharmacokinetics

Substanzen

AcetonitrilesAZD7648PurinesPyransTriazoles

Autor:innen und Institutionen

  • Department of Pharmacy, Yingshang People's Hospital, Fuyang, Anhui Province, China.
  • School of Medicine, Jinan University, Guangzhou, Guangdong Province, China.
  • School of Integrated Traditional Chinese and Western Medicine, Binzhou Medical University, Yantai, Shandong Province, China.

ORCID-Profile: Jichun Han

Zitieren

APA

Fang, X., Lu, Q., & Han, J. (2024). Development and validation of an LC–MS/MS method for the determination of AZD7648 in rat plasma: Application to a pharmacokinetic study. Biomedical Chromatography. https://doi.org/10.1002/bmc.5765

Vancouver

Fang X, Lu Q, Han J. Development and validation of an LC–MS/MS method for the determination of AZD7648 in rat plasma: Application to a pharmacokinetic study. Biomedical Chromatography. 2024. doi:10.1002/bmc.5765

BibTeX
@article{Fang2024,
  author = {Fang, Xun and Lu, Qi and Han, Jichun},
  title = {Development and validation of an LC–MS/MS method for the determination of AZD7648 in rat plasma: Application to a pharmacokinetic study},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5765}
}
Kostenlos starten →